谷歌浏览器插件
订阅小程序
在清言上使用

Lipid and Transcriptional Regulation in a Parkinson's Disease Mouse Model by Intranasal Vesicular and Hexosomal Plasmalogen-Based Nanomedicines

Advanced healthcare materials/Advanced Healthcare Materials(2024)

引用 0|浏览20
暂无评分
摘要
Plasmalogens (vinyl-ether phospholipids) are an emergent class of lipid drugs against various diseases involving neuro-inflammation, oxidative stress, mitochondrial dysfunction, and altered lipid metabolism. They can activate neurotrophic and neuroprotective signaling pathways but low bioavailabilities limit their efficiency in curing neurodegeneration. Here, liquid crystalline lipid nanoparticles (LNPs) are created for the protection and non-invasive intranasal delivery of purified scallop-derived plasmalogens. The in vivo results with a transgenic mouse Parkinson's disease (PD) model (characterized by motor impairments and alpha-synuclein deposition) demonstrate the crucial importance of LNP composition, which determines the self-assembled nanostructure type. Vesicle and hexosome nanostructures (characterized by small-angle X-ray scattering) display different efficacy of the nanomedicine-mediated recovery of motor function, lipid balance, and transcriptional regulation (e.g., reduced neuro-inflammation and PD pathogenic gene expression). Intranasal vesicular and hexosomal plasmalogen-based LNP treatment leads to improvement of the behavioral PD symptoms and downregulation of the Il6, Il33, and Tnfa genes. Moreover, RNA-sequencing and lipidomic analyses establish a dramatic effect of hexosomal nanomedicines on PD amelioration, lipid metabolism, and the type and number of responsive transcripts that may be implicated in neuroregeneration. Liquid crystalline lipid nanoparticles derived from plasmalogen bioactive lipids (an emergent drug class for nanomedicine development against neurodegenerative disorders) are found to produce positive but distinct outcomes after 1-month non-invasive intranasal drug delivery in a transgenic mouse model of Parkinson's disease. RNA-Seq and lipidomics identify key genes and lipid types responsive to plasmalogen-based nanomedicine treatment. image
更多
查看译文
关键词
hexosomes,in vivo Parkinson's disease transgenic mouse model,liquid crystalline lipid nanoparticles,nanomedicine,RNA-seq
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要